The purpose of this study is to see if the study eye drop can slow the progression of myopia in children.
Two different doses of the study eye drop will be compared to a placebo eye drop, which looks like the study eye drop but contains no active medication.
The study will determine how well the study eye drop works, while also checking its safety.
The results of this study may help children with nearsightedness in the future.
By participating in this study, the child becomes an important part of the effort to learn more about myopia and how to slow down the myopic progression that usually happens in childhood.
The study eye drop has not been approved by the United States Food and Drug Administration (FDA) and is considered “investigational.”Who is Eligible?